⌘K

Login Start Free

Home/Filings/4/0001493152-23-043749

4//SEC Filing

Sragovicz Adam 4

Accession 0001493152-23-043749

CIK 0001896212other

View on SEC.gov Company Profile

Filed

Dec 4, 7:00 PM ET

Accepted

Dec 5, 5:20 PM ET

Size

4.8 KB

Accession

0001493152-23-043749

Insider Transaction Report

Form 4

Period: 2023-12-01

CONDUIT PHARMACEUTICALS INC.CDT

DirectorCFO and Treasurer

Transactions

Award
Restricted Stock Units
2023-12-01+74,545→ 74,545 total

Footnotes (1)

[F1]The restricted stock units were granted with a vesting schedule of 33.3% on each of the first three anniversaries of the vesting commencement date, which is September 22, 2023.

Documents

1 file

4
ownership.xmlPrimary

Issuer

CONDUIT PHARMACEUTICALS INC.

CIK 0001896212

Entity typeother

Related Parties

1

filerCIK 0001727723

Filing Metadata

Form type: 4
Filed: Dec 4, 7:00 PM ET
Accepted: Dec 5, 5:20 PM ET
Size: 4.8 KB

View on SEC.gov